DC360 — Powered by Drug Channels

Analysis

The latest Drug Channels commentary — PBMs, 340B, specialty pharmacy, and the contracts that move the money.

Showing 691–700 of 2721

Monday, April 19, 2021

  • Informa Connect’s Compliance Congress for Specialty Products

    Informa Connect’s Compliance Congress for Specialty Products
    June 22-24, 2021 | Virtual Event
    www.informaconnect.com/specialty-compliance/

    Exclusive Offer: Use promo code SPECIALTY10 to save 10% off* your registration fee.

    Up your compliance game at this important event serving the unique sector of Specialty Products, the 7th annual Virtual Compliance Congress for Specialty Products. Join the compliance community for dynamic discussions on the top risk areas for specialty pharmaceutical companies, including speaker programs, patient support programs, charitable donations, specialty pharmacy relationships, patient advocacy group interactions, mergers and acquisitions, medical affairs activities, drug pricing, transparency and more!

    The Compliance Congress for Specialty Products serves as a three-day conference experience, featuring top experts ready to lead robust discussions on the current and changing environment, industry best practices, hot-button topics and more, including:
    • Enforcement Trends & Prosecutor Perspectives
    • COVID-19 Impacts & Aftermath
    • Crisis Management & Business Continuity
    • Patient Interactions & Support Programs
    • Virtual/Digital Engagement & Monitoring
    • Transparency & Aggregate Spend
    • Drug Pricing Legislation & Transparency
    • Compliance Training & Culture Development
    • Speaker Programs
    • And more!
    Outstanding Virtual Capabilities:
    • Interactive presentations and panels
    • Live Q&A and polling
    • Live and on-demand sessions, all available 30-days post-event to review at your leisure
    • 1-1 meeting opportunities and peer-to-peer engagement
    • Sophisticated and seamless scheduling tools
    PLUS: Advance Your Career with CLE, CPE & CCB accredited content!

    Exclusive Offer – View the full agenda and register today. Use promo code SPECIALTY10 to save 10% off* your registration fee.

    Informa Connect will see you there!

    *Cannot be combined with other offers, promotions or applied to an existing registration. Other restrictions may apply.

    The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. To find out how you can reach the Drug Channels audience, please contact Paula Fein (paula@DrugChannels.net).


    Read more

    Posted by Drug Channels Institute, an HMP Global company on Monday, April 19, 2021

    Labels: Sponsored Post

Friday, April 16, 2021

Wednesday, April 14, 2021

  • Gross-to-Net Bubble Update: Net Prices Drop (Again) at Six Top Drugmakers

    Time for Drug Channels' annual update on pricing at six of the largest pharmaceutical manufacturers—Eli Lilly, GlaxoSmithKline, Janssen, Merck, Novartis, and Sanofi. You can find links to each company’s data below.

    When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2020. Consistent with our previous analyses, rebates and discounts reduced the selling prices of brand-name drugs to less than half of their list prices. What’s more, net drug prices have declined for the past four years.

    Alas, many pharma industry perma-critics refuse to accept that brand-name drug prices are falling—or that they remain the only part of U.S. healthcare where prices have been declining. That’s why they are drug pricing flat earthers (DPFE.) Consider today’s data deluge as my small contribution to making the world a slightly smarter and more fact-based place.
    Read more

    Posted by Drug Channels Institute, an HMP Global company on Wednesday, April 14, 2021

    Labels: Gross-to-Net Bubble, Costs/Reimbursement, Industry Trends, Medicaid, PBMs, Medicare Part D

Monday, April 12, 2021

  • Informa Connect’s Patient Support Services Congress

    Informa Connect’s Patient Support Services Congress
    June 15-17, 2021 | VIRTUAL EVENT (All-Digital Format)
    www.informaconnect.com/patient-support-services/

    Patient Support Services is a dialogue driven meeting that arms the industry with trends and next-generation approaches to patient services for optimal performance. Showcasing innovative discussions on access strategy, patient interactions, case management, compliance practices and more, this two-and-a-half-day event navigates a myriad and mounting level of compliance hurdles while strengthening and innovating patient-oriented programs.

    Drug Channels readers save 10% off the current registration rate with promo code 21PSSDC10.* Register today.

    In-Depth Discussions and Actionable Takeaways on Critical Topics:
    • Keep a Pulse on Emerging Trends for 2021 — Update on Drug Pricing Pressures, Patient Assistance Programs, Evolving Copay Card Legislation and Formulary Transformations
    • Enforcement Update — Oversight and High Priority Risk Areas for Patient Services
    • Industry Playbook for Risk Mitigation — Leading Frameworks to Enhance your Compliance Strategy
    • Enhance the Stakeholder Experience — Operational Insights on Specialty Patient Connectivity
    • Capture and Optimize Patient Data to Create an Integrated Experience
    Customizable Experience with Two Tailored Tracks:
    • Legal and Compliance
    • Innovation and Operations
    Featured Faculty Driving the Conversation:
    • Esther Langer, Head of US Patient Services, Trade and Distribution, Apellis Pharmaceuticals
    • Paul J. Koob, Assistant U.S. Attorney, U.S. Attorney’s Office for the Eastern District of Pennsylvania
    • Jolie Apicella, Assistant U.S. Attorney, Chief, Health Care Fraud, U.S. Attorney’s Office, Eastern District of New York
    • Rahul Khara, Pharm.D., Vice President, Legal and Chief Compliance Officer, Acceleron Pharma Inc.
    • Amy Wilson, Head, U.S. Compliance, Morphosys
    • Karen Tenenbaum, Vice President, Assistant General Counsel, Head of Legal, Salix
    • Liam Moy, Senior Director, Patient Services, Neurology, Alexion Pharmaceuticals
    • Katherine Chaurette, Vice President Healthcare Law and Compliance, Blueprint Medicines
    • Dave MacLeod, Head of Patient Services and Specialty Pharmacy Operations, Amylyx Pharmaceuticals
    • Robert Britting, Director, Patient Services and Strategic Solutions, Teva Pharmaceuticals
    • And so many more!
    Comprehensive Content and Dynamic Features Include:
    • 3 days of live content from industry thought-leaders
    • 10+ on-demand sessions, tailored to both access and compliance
    • Over 4 hours of live speaker Q&A
    • AI-powered virtual networking with colleagues and counterparts
    • Private meeting and chat rooms
    • Access to live and on-demand content for 30 days post-event
    Drug Channels readers save 10% off the current registration rate with promo code 21PSSDC10. Register today.

    *Offer applies to standard rates only and may not be combined with other offers, category rates, promotions or applied to an existing registration. Offer not valid on workshop only or academic/non-profit registrations.

    The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

    Read more

    Posted by Drug Channels Institute, an HMP Global company on Monday, April 12, 2021

    Labels: Sponsored Post

Friday, April 9, 2021

Tuesday, April 6, 2021

  • The Top Pharmacy Benefit Managers of 2020: Vertical Integration Drives Consolidation

    The drug channel is consolidating, both vertically and horizontally.

    For evidence, look no further than Drug Channels Institute's estimates of pharmacy benefit manager (PBM) market share, which are shown in the chart below. For 2020, DCI estimates that the three biggest PBMs accounted for more than three-quarters of total equivalent prescription claims.

    To help you make sense of recent market changes, I also include a brief video explaining how various transactions and partnerships have concentrated and shifted PBM share among the vertically integrated companies. The video is excerpted from my recent Patients, Payers, and PBMs webinar.

    Depending on your role in the drug channel, you may or may not find these data terrifying.
    Read more

    Posted by Drug Channels Institute, an HMP Global company on Tuesday, April 6, 2021

    Labels: Mergers and Acquisitions, Industry Trends, Video, Channel Management, PBMs

Thursday, April 1, 2021

  • Streamlining the Specialty Therapy Prescribing and Enrollment Experience

    Today’s guest post comes from Megan Marchal, CoverMyMeds Specialty Pharmacy’s pharmacist in charge.

    Megan discusses a recent enhancement to AMP: Access for More Patients™ (AMP), a tech-enabled hub and patient access service from CoverMyMeds and RxCrossroads by McKesson. Read more about technology and patient access in CoverMyMeds’ 2021 Medication Access Report.

    Read on for Megan’s insights.
    Read more

    Posted by Drug Channels Institute, an HMP Global company on Thursday, April 1, 2021

    Labels: Guest Post, Sponsored Post

Wednesday, March 31, 2021

Monday, March 29, 2021

  • Informa Connect's Medicaid and Government Pricing Congress

    Medicaid and Government Pricing Congress
    June 8-11, 2021 | Virtual Event
    www/informaconnect.com/medicaid-congress

    Register today using the exclusive Drug Channels discount code 21MDGP10 to receive 10% off!

    The Medicaid and Government Pricing Congress, an important event dedicated to critical policy updates and approaches to effectively contract, report and comply with state and federal healthcare programs, returns June 8-11, 2021.

    Hear from GP Experts on MDRP trends and strategies and the impacts from the change to a new administration. The 2021 event has a content-rich agenda, providing the most up-to-date content and topics based on the ever-changing political and regulatory environment, fresh perspectives from small to big pharma and more interaction in the virtual environment.

    Up-To-Date Content

    We’ve got all of the key legal and consultant perspectives on topics like 340B (including contract pharmacy arrangements), State Price Transparency, CMS current and final rules, Most Favored Nations, and more!

    Fresh Perspectives

    Along with many of the well-respected experts typically on the program from companies like Gilead, Sandoz, CMS, AstraZeneca, Pfizer and Regeneron, we’ve added new speakers form Amgen, Jazz Pharmaceuticals, Novartis and more!

    More Interaction

    In addition to our select Panel Discussions and the insightful Fireside Chat with Outside Counsel, we’ve added interactive working groups led by expert Facilitators from manufacturers, law firms, and consulting groups to discuss everything from Product Launch, Divestiture and Acquisition Challenges to State Dispute Resolution and Collaboration during the pandemic, to State Price Transparency and Reporting.

    PLUS our world-class content including topics like the in-depth GP 101 Bootcamp, operational effectiveness sessions, updates from OIG and more! Register today using the exclusive Drug Channels discount code 21MDGP10 to receive 10% off!

    The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

    Read more

    Posted by Drug Channels Institute, an HMP Global company on Monday, March 29, 2021

    Labels: Sponsored Post

Friday, March 26, 2021

Trusted worldwide

Stay Informed. Stay Ahead.

Subscribe to our newsletter for the latest analysis and industry updates.